Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ENVB
ENVB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ENVB News
Lakewood-Amedex Appoints New Board Member to Strengthen Governance
5d ago
PRnewswire
Lakewood-Amedex Appoints New Board Member to Strengthen Governance
5d ago
Newsfilter
U.S. Stocks Rally with Tech Gains, Near All-Time Highs
Apr 24 2026
stocktwits
FDA Accelerates Development of Psychedelic Treatments for Mental Health
Apr 24 2026
stocktwits
AtaiBeckley Price Target Raised to $15 Amid Positive Drug Trial News
Apr 20 2026
stocktwits
Trump Signs Executive Order to Accelerate Psychedelic Drug Reviews
Apr 20 2026
Newsfilter
FDA Prioritizes Review of Psychedelic Treatments
Apr 20 2026
stocktwits
Enveric Biosciences Closes $5 Million Financing
Apr 17 2026
Newsfilter
ENVERIC BIOSCIENCES COMPLETES PRIVATE PLACEMENT OF UP TO $13.9 MILLION PRICED AT MARKET VALUE UNDER NASDAQ REGULATIONS
Apr 17 2026
moomoo
Enveric Plans to Fund Product Development Through Offering
Apr 17 2026
stocktwits
Enveric Biosciences Announces Stock Offering Plan
Apr 17 2026
seekingalpha
Enveric Biosciences Secures $5 Million in Private Placement Financing
Apr 17 2026
Newsfilter
Enveric Biosciences Reports Q4 2025 Financial Results
Mar 30 2026
seekingalpha
Enveric Biosciences Advances EB-003 Clinical Research
Mar 28 2026
stocktwits
ENVB Stock Falls in After-Hours Trading Due to Increased Q4 Losses Despite Advancements in Psychiatry Drug Research
Mar 28 2026
stocktwits
Enveric Biosciences Advances EB-003 Drug Development with Positive Preclinical Results
Mar 27 2026
Newsfilter
Show More News
